Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Phase 3 Unknown
108 enrolled
Family History Study on Cancer Risk
Phase NA Unknown
18,623 enrolled
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Phase 1 Unknown
10 enrolled
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
Phase 2 Unknown
62 enrolled
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Phase 1 Unknown
42 enrolled
Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer
Phase 2 Unknown
24 enrolled
AMT-151 in Patients With Selected Advanced Solid Tumours
Phase 1 Unknown
30 enrolled
Malignant Pediatric Pelvic Tumors: A Retrospective Study
Unknown
90 enrolled
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Phase 1/2 Unknown
314 enrolled
THE EFFECT OF CANCER EDUCATION ON WOMEN'S AWARENESS LEVELS AND THEIR BEHAVIORS ON SCREENINGS
Phase NA Unknown
60 enrolled
ELISA
Unknown
320 enrolled
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Unknown
3,000 enrolled
RESTORE
Phase NA Unknown
352 enrolled
GEMS
Phase NA Unknown
40 enrolled
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Unknown
133 enrolled
MICROBIOME
Phase 1 Unknown
120 enrolled
Mobile Health Application Developed for Cervical Cancer
Phase NA Unknown
48 enrolled
PASSION
Unknown
1,800 enrolled
COPELIA
Phase 2 Unknown
124 enrolled
Urine-hrHPV
Unknown
1,000 enrolled
Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer
Phase NA Unknown
150 enrolled
Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer
Phase 1/2 Unknown
85 enrolled
BE-BALANCED
Phase NA Unknown
30 enrolled
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
Unknown
3,000 enrolled
PIONEER
Unknown
1,000 enrolled
AVANIRA3
Phase 2 Unknown
32 enrolled
ANLOLA
Phase 2 Unknown
68 enrolled
Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations
Phase 4 Unknown
217 enrolled
IOTA-MRI
Phase NA Unknown
250 enrolled
IOTA7
Unknown
1,700 enrolled
MMIPC
Phase 1/2 Unknown
29 enrolled
V3-OVA
Phase 2 Unknown
20 enrolled
GENEPY
Unknown
450 enrolled
Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Phase 2 Unknown
100 enrolled
A Study Evaluating MM-310 in Patients With Solid Tumors
Phase 1 Unknown
34 enrolled
The Application of Invivo Microscopy Imaging in the Early Diagnosis of Cervical Cancer
Phase NA Unknown
600 enrolled
Intra-peritoneal Chemotherapy in Ovarian Cancer
Unknown
15 enrolled
Cancer Prevention in Women With a BRCA Mutation
Phase 1 Unknown
300 enrolled
GENIUS
Unknown
25 enrolled
A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
Phase 1 Unknown
40 enrolled
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Phase 1 Unknown
20 enrolled
Hypodontia and Ovarian Cancer
Unknown
200 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies
Phase 1 Unknown
12 enrolled
Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA)
Phase 1/2 Unknown
15 enrolled
Early Detection of Cancers in Low Resource Countries
Unknown
36,000 enrolled
The Association Between Cervical Cancer Screening and Cancer Occurrence
Unknown
6,000,000 enrolled
Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function
Unknown
200 enrolled
Blood Test for Ovarian Cancer Associated Antibodies (CAAb)
Unknown
60 enrolled
A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies
Phase 1/2 Unknown
40 enrolled